These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 20714679)
1. Carnitine-acylcarnitine translocase deficiency. Clinical course of three Saudi children with a severe phenotype. Al-Sannaa NA; Cheriyan GM Saudi Med J; 2010 Aug; 31(8):931-4. PubMed ID: 20714679 [TBL] [Abstract][Full Text] [Related]
5. Carnitine-acylcarnitine translocase deficiency. Clinical course of 3 Saudi children with a severe phenotype. Al-Mendalawi MD Saudi Med J; 2011 Feb; 32(2):203; author reply 203. PubMed ID: 21301774 [No Abstract] [Full Text] [Related]
6. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response. Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972 [TBL] [Abstract][Full Text] [Related]
7. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts. Pande SV; Brivet M; Slama A; Demaugre F; Aufrant C; Saudubray JM J Clin Invest; 1993 Mar; 91(3):1247-52. PubMed ID: 8450053 [TBL] [Abstract][Full Text] [Related]
12. Identification of two novel mutations of the carnitine/acylcarnitine translocase (CACT) gene in a patient with CACT deficiency. Ogawa A; Yamamoto S; Kanazawa M; Takayanagi M; Hasegawa S; Kohno Y J Hum Genet; 2000; 45(1):52-5. PubMed ID: 10697964 [TBL] [Abstract][Full Text] [Related]
13. Three novel mutations in the carnitine-acylcarnitine translocase (CACT) gene in patients with CACT deficiency and in healthy individuals. Fukushima T; Kaneoka H; Yasuno T; Sasaguri Y; Tokuyasu T; Tokoro K; Fukao T; Saito T J Hum Genet; 2013 Dec; 58(12):788-93. PubMed ID: 24088670 [TBL] [Abstract][Full Text] [Related]
14. Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation. Iacobazzi V; Pasquali M; Singh R; Matern D; Rinaldo P; Amat di San Filippo C; Palmieri F; Longo N Am J Med Genet A; 2004 Apr; 126A(2):150-5. PubMed ID: 15057979 [TBL] [Abstract][Full Text] [Related]
15. Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: Two case reports and brief literature review. Yan HM; Hu H; Ahmed A; Feng BB; Liu J; Jia ZJ; Wang H Medicine (Baltimore); 2017 Nov; 96(45):e8549. PubMed ID: 29137068 [TBL] [Abstract][Full Text] [Related]
16. A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype. Morris AA; Olpin SE; Brivet M; Turnbull DM; Jones RA; Leonard JV J Pediatr; 1998 Mar; 132(3 Pt 1):514-6. PubMed ID: 9544911 [TBL] [Abstract][Full Text] [Related]
17. Carnitine-acylcarnitine translocase deficiency in three neonates presenting with rapid deterioration and cardiac arrest. Lee RS; Lam CW; Lai CK; Yuen YP; Chan KY; Shek CC; Chan AY; Chow CB Hong Kong Med J; 2007 Feb; 13(1):66-8. PubMed ID: 17277394 [TBL] [Abstract][Full Text] [Related]
18. Familial neonatal SIDS revealing carnitine-acylcarnitine translocase deficiency. Nuoffer JM; de Lonlay P; Costa C; Roe CR; Chamoles N; Brivet M; Saudubray JM Eur J Pediatr; 2000; 159(1-2):82-5. PubMed ID: 10653336 [TBL] [Abstract][Full Text] [Related]
19. Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle. Röschinger W; Muntau AC; Duran M; Dorland L; IJlst L; Wanders RJ; Roscher AA Clin Chim Acta; 2000 Aug; 298(1-2):55-68. PubMed ID: 10876004 [TBL] [Abstract][Full Text] [Related]
20. Carnitine-acylcarnitine translocase deficiency: case report and review of the literature. Rubio-Gozalbo ME; Vos P; Forget PP; Van Der Meer SB; Wanders RJ; Waterham HR; Bakker JA Acta Paediatr; 2003 Apr; 92(4):501-4. PubMed ID: 12801121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]